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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S91Results: GRP was detected by IHC throughout all mineralized areas in non-
decalciﬁed tissue samples, both in calciﬁed cartilage and bone, as well as in
the hyaline cartilage and chondrocytes. Decalciﬁcation of those tissue
sections resulted in the loss of GRP signal associated with the mineralized
matrixes, and clearly identiﬁed GRP within osteoblasts and osteocytes in
bone, in agreementwith GRP pattern of accumulationpreviously seen in rat
skeletal tissues. Evidences for GRP accumulation in the osteoclasts were
also seen, but this result needs further conﬁrmation. In the synovial
membrane, GRP was found highly associated with speciﬁc cell types at the
synovial lining layer, within synoviocytes and in endothelial cells of capil-
laries and sporadically in some ﬁbroblasts of the connective sublining layer.
At sites of calciﬁcation GRP was detected co-localized with the mineral
deposits. The detection of GRP in synoviocytes lead us to investigate the
presence of GRP in the synovial ﬂuid and the results obtained by Western
blot analysis, either using the common or 2-D electrophoresis, pointed to
the existence of several forms of GRP in this body ﬂuid. Cartilage extracts
analyzed by Western blot also showed the presence of several GRP forms.
Altogether these results point to the existence of several forms of GRP in
human.However, PCR ampliﬁcations using different sets of speciﬁc primers
always resulted in the ampliﬁcation of only the F1 isoform andno evidences
were found for the existence of additional GRP spliced transcripts.
Conclusions: Our results show that in OA, GRP is accumulated in the
articular and calciﬁed cartilage, subchondral bone, synovial membrane
and synovial ﬂuid. The detection of GRP co-localized with the ectopic
mineral deposits present in OA, conﬁrms the association of this protein to
pathological calciﬁcations. Furthermore our results show that GRP is also
highly accumulated at sites of inﬂammation associated with OA, and could
indicate an active role of this Gla protein in inﬂammation processes.
Although wewere able to conﬁrm the presence of isoform F1, we found no
evidence for the existence in human of the other 3 alternatively spliced
transcripts of the GRP gene (F2, F3 and F4) described to exist in mouse,
suggesting that the different GRP forms detected by Western blot might
correspond to different g-carboxylation status of the protein.
At the moment a speciﬁc ELISA assay for GRP detection is being developed
and will enable unveiling the relation between levels and forms of GRP in
the synovial ﬂuid with OA severity, providing a new tool that might be
relevant in OA assessment and diagnosis.
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NEW URINE BIOMARKER ASSAY COMPARES TO SYNOVIAL FLUID
CHANGES AFTER ACUTE JOINT INJURY IN AN EQUINE MODEL OF
OSTEOARTHRITIS
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Purpose: It has been well documented that collagenase cleavage of type II
collagen occurs during osteoarthritis (OA) and that neoepitopes created by
this cleavage can be identiﬁed and semi-quantiﬁed in the synovial ﬂuid
(SF) and serum. Recently, a new sandwich assay for urine (IB-C2C-EUSA;
IBEX Pharmaceutical Inc) was developed that detects an intrachain epitope
within 45 residues of the neoepitope on the Carboxy-terminal 3/4 frag-
ment. The purpose of this study was to use this sandwich assay to deter-
mine if acute changes could be identiﬁed in equine urine following
osteochondral (OC) injury and compare the ﬁndings to SF.
Methods: Twenty-two clinically and radiographically normal age- and
sex-matched Quarter Horses were randomly divided into 2 groups: (1)
horses (n¼11) that had an OC fragment created arthroscopically in one
randomly selectedmetacarpophalangeal (MCP) joint and a sham operation
in the contralateral joint at week 0; and (2) unoperated exercise control
horses (n¼11). All horses were exercised on a treadmill from week 2 to
week 16. Urine was collected via catheterization mid-morning in all
horses. Blood was collected from the jugular vein and SF samples were
collected without lavage from both MCP joints of all horses at baseline
(week 0), and weeks 1, 2, 4, 8, 12, and 16. IB-C2C-EUSA kits were provided
by IBEX. Other commercially available ELISA assays were purchased (C2C
[IBEX], CTXII [IDS/Nordic], and MicroVue Creatinine [Quidel Corp]) and
were used to analyze SF and serum or urine samples. IB-C2C-EUSA results
were analyzed with and without creatinine (Cr) correction and the percent
change from baseline was calculated. Normality was assessed and outliersremoved. A repeated measures ANOVA with a Tukey's test for multiple
comparisons was used for all analyses. Correlations between biomarkers
were performed using Spearman Rank. P 0.05 was considered signiﬁcant.
Results: There was a signiﬁcant effect of time (P¼0.003), group (P¼0.013)
and the interaction between group and time (P¼0.006) for the percent
change from baseline of IB-C2C-EUSA concentrations that were not Cr
adjusted (uC2C; Fig 1a). This is similar to SF C2C concentrationswhere there
is also a signiﬁcant effect of time, group, and the interaction (P<0.0001 for
all; Fig 1b). With both assays, OC injured horses had greater change over
time than the control group or shams, as demonstrated by IB-C2C-EUSA
urine samples being signiﬁcantly elevated above baseline and controls at
week 1 and SF C2C samples being elevated above shams and controls from
week1 to week 16 (Fig 1). Adjustment of IB-C2C-EUSA samples with Cr (as
well as percent change) did not allow for any separation between groups.
However, correlation analyses were similar regardless of whether Cr was
adjusted for or not. Cr adjusted IB-C2C-EUSA concentrations were nega-
tively correlated to age (R¼ -0.569; P¼0.0001), SF C2C (R¼ -0.127; P¼0.03),
SF:serum C2C ratio (R¼ -0.152; P¼0.009), and were positively correlated to
urine CTX-II concentrations (R¼0.685; P¼0.0001).
Conclusions: Our results demonstrate that the IB-C2C-EUSA sandwich
assay for equine urine can identify acute changes that occur in response to
injury that is similar to the response identiﬁed in SF. In most equine
biomarker studies, the only changes that occur within one week after
injury to a single limb are in the SF. The results of this study suggest
however, that IB-C2C-EUSA has the potential to identify these early
changes as well, allowing for less invasive testing procedures. Further
investigation will need to be performed to determine future recommen-
dations regarding creatinine adjustment.
Figure 1. a) Percent change from baseline (SD) for IB-C2C-EUSA
concentrations (not Cr adjusted) for osteochondral (OC) injured and
control horses. b) Synovial ﬂuid C2C concentrations for OC injured and
sham limbs, and controls. OC injured to baseline: +++ ¼ P<0.001, ++ ¼
P<0.01; OC injured to sham: *** ¼ P<0.001; OC injured to controls: ^^^ ¼
P<0.001, ^ ¼ P<0.05; sham to control: ## ¼ P<0.01.
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SYNOVIAL FLUID BIOMARKERS OF INNATE IMMUNE ACTIVITY ARE
PREDICTIVE OF KNEE OSTEOARTHRITIS PROGRESSION
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